Non–prostate cancer mortality was similar in all HSD3B1 groups with 171 events in patients with the AA genotype (5.9%), 116 events (5.9%) in patients with the AC genotype, and 25 events (6.2%) in patients with the CC genotype. The gene discussed is HSD3B1; the disease is prostate carcinoma.